Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | IMGS-001 |
| Trade Name | |
| Synonyms | IMGS001|IMGS 001 |
| Drug Descriptions |
IMGS-001 is a monoclonal antibody that targets CD274 (PD-L1) and PDCD1LG2 (PD-L2), potentially leading to antibody-dependent cellular cytotoxicity and tumor growth inhibition (Journal for ImmunoTherapy of Cancer 2022;10). |
| DrugClasses | PD-L1 Inhibitor 15 |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| IMGS-001 | IMGS-001 | 0 | 1 |